Skadden is representing Veloxis Pharmaceuticals in its suit against the FDA to reverse its decision to delay approval of Veloxis’ new drug Envarsus XR.
Skadden is advising Visteon Corporation in its agreement to sell its approximately 70 percent ownership interest in Halla Visteon Climate Control Corp.
Skadden is advising Fortune Dynasty in connection with its recommended acquisition of LSE-listed Fortune Oil plc, which values Fortune Oil at up to $606 million.
Skadden is advising Ladder Capital Corp in its plans to elect real estate investment trust status.
Skadden secured another victory on December 16 on behalf of Tremont Group Holdings, Inc. in ongoing litigation arising out of Bernard Madoff's Ponzi scheme.
Skadden is advising Longview Asset Management, LLC as a stockholder of PetSmart, Inc., in PetSmart's $8.7 billon acquisition by a consortium led by BC Partners, Inc.
Skadden has announced its 2015 class of Skadden Fellows, a group of 28 graduating law students and judicial clerks who are devoting the next two years of their professional careers to public interest work.
The Hong Kong office was given the "2014 Distinguished Pro Bono Law Firm Award” by the Law Society of Hong Kong on December 5.
Skadden, Arps is pleased to announce that Olivier Diaz, one of France's most highly regarded corporate and M&A practitioners, will join our Paris office as a partner to further enhance the firm’s market-leading M&A capabilities. He also will become part of the firm's global Corporate Group.
The Human Rights Campaign Foundation again named Skadden as one of the "Best Places to Work for LGBT Equality."